Lana Kandalaft
Chief, Clinical & Translational Research Swiss Medical Network
Seminars
Thursday 3rd December 2026
From Whole-Tumor Vaccines to Personalized Peptides: Lessons from Clinical Translation
9:40 am
- Evolution of cancer vaccines from whole-tumor and dendritic-cell approaches to personalized peptide vaccines
- Translating personalized peptide vaccines into clinical practice across solid tumors using advanced neoantigen prediction and selection
- Integrating sophisticated immune monitoring, including next-generation TCR sequencing, to assess vaccine-induced immune responses and guide future vaccine development
